Myrbetriq
Generic name: Mirabegron
Drug class:
Urinary antispasmodics
Usage of Myrbetriq
Myrbetriq relaxes the muscles of the urinary bladder, reducing bladder spasms. It is used alone or with solifenacin succinate to treat the symptoms of overactive bladder, such as frequent or urgent urination and urinary incontinence.
Myrbetriq is used in adults to treat overactive bladder with symptoms of frequent or urgent urination and urinary incontinence. It is sometimes used together with another medicine called solifenacin (Vesicare).
Myrbetriq is used in children to treat neurogenic detrusor overactivity (NDO). Urinary incontinence caused by NDO is related to permanent nerve damage from conditions such as multiple sclerosis or spinal injury.
Myrbetriq tablets may be used in children at least 3 years old. Myrbetriq granules are for use in children at least 3 years old who also weigh at least 77 pounds (35 kilograms).
Myrbetriq side effects
Stop using Myrbetriq and get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
Common Myrbetriq side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Myrbetriq
You should not use Myrbetriq if you are allergic to mirabegron.
To make sure this medicine is safe for you, tell your doctor if you have:
Tell your doctor if you are pregnant or breastfeeding.
Myrbetriq should not be given to a child younger than 3 years old.
Relate drugs
- Anturol
- Atropine, hyoscyamine, methenamine, methylene blue, phenyl salicylate, and benzoic acid
- Azuphen MB
- Myrbetriq
- Myrbetriq Granules
- Darifenacin
- Detrol
- Detrol LA
- Ditropan
- Ditropan XL
- Enablex
- Fesoterodine
- Flavoxate
- Gelnique
- Gelnique transdermal
- Gemtesa
- Hyolev MB
- Hyoscyamine, methenamine, methylene blue, and sodium biphosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, and sodium phosphate
- Hyoscyamine, methenamine, methylene blue, phenyl salicylate, sodium biphosphate
- Mirabegron
- Oxybutynin
- Oxybutynin (Oral)
- Oxybutynin transdermal
- Oxytrol
- Phosphasal
- Prosed EC
- Sanctura
- Sanctura XR
- Solifenacin
- Tolterodine
- Toviaz
- Trac Tabs
- Trospium
- UR N-C
- Uramit MB
- Urelle
- Uretron D/S
- Uribel
- Urimar-T
- Urin D/S
- Urised
- Urispas
- Uro-L
- Uro-MP
- Urogesic-Blue
- Ustell
- UTA
- Uticap
- Utira-C
- Utrona-C
- VESIcare
- VESIcare LS
- Vibegron
- Vilamit MB
- Vilevev MB
How to use Myrbetriq
Take Myrbetriq exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets.
If you take Myrbetriq with solifenacin, take both medicines at the same time each day.
Take the Myrbetriq tablet with a full glass of water. Swallow the tablet whole and do not crush, chew, or break it.
An adult may take a Myrbetriq tablet with or without food. However, a child should take the tablet with food.
Both adults and children should take Myrbetriq granules with food.
A pharmacist will mix the granules into a suspension (liquid) before you receive the medicine.
Shake the suspension before you measure a dose. Use the dosing syringe provided, or use a medicine dose-measuring device (not a kitchen spoon).
If the suspension will not be used for 2 days or longer, shake the bottle vigorously for 1 minute each day to keep the granules thoroughly mixed.
Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you do not understand these instructions.
Your dose needs may change if you switch from using tablets to using the suspension. Avoid medication errors by using only the form and strength your doctor prescribes.
Your blood pressure will need to be checked often.
It may take up to 8 weeks before your symptoms improve. Keep using the medication as directed and tell your doctor if your symptoms do not improve.
Store at room temperature away from moisture and heat. Throw away any unused Myrbetriq suspension after the expiration date on the medicine label has passed.
Warnings
You should not use Myrbetriq if you have
A condition called angioedema can occur after taking Myrbetriq. Angioedema is a condition that leads to face, lip, tongue, throat swelling, difficulty breathing and can be fatal. Seek emergency attention immediately if these symptoms occur.
It may take up to 8 weeks before your symptoms improve. Keep using this medicine as directed and tell your doctor if your symptoms do not improve after 8 weeks of treatment.
What other drugs will affect Myrbetriq
Tell your doctor about all your other medicines, especially:
This list is not complete. Other drugs may interact with mirabegron, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible drug interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions